Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (TBPH)
CUSIP: G8807B106
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares")
- Total 13F shares
- 44,895,013
- Total 13F value
- $400,910,124
- Share change
- +116,751
- Put/Call ratio
- 200%
- SEC-reported price per share
- $8.93
- Number of holders
- 130
- Value change
- +$805,783
- Number of buys
- 56
- Number of sells
- 64
- Shares outstanding
- 52,046,621
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
130
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
Madison Avenue Partners, LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
3/4/5
Lead comparable stake: 6.5%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 6.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
6.5%
Madison Avenue Partners, LP
18%
Weiss Asset Management LP
14%
Newtyn Management, LLC
9.1%
Irenic Capital Management LP
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$34,932,773
3,712,303 shares
|
— | 31 Dec 2024 |
| Madison Avenue Partners, LP |
13F
Company
|
18%
|
$89,499,922
9,511,150 shares
|
— | 31 Dec 2024 |
| Weiss Asset Management LP |
3/4/5
13F
10%+ Owner · Company
|
14%
from 13F
|
$76,733,147
7,457,060 shares
|
— | 19 Sep 2022 |
| Newtyn Management, LLC |
13F
Company
|
9.1%
|
$44,767,162
4,757,403 shares
|
— | 31 Dec 2024 |
| Irenic Capital Management LP |
13F
Company
|
5.3%
|
$25,980,521
2,760,948 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.9%
|
$18,919,219
2,010,544 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
130
Shares
44,895,013
Rows available
130
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
130
Q1 2025 holders
130
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|